Cue Biopharma, Inc. Annual Return On Assets in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Cue Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from 2018 to 2023.
  • Cue Biopharma, Inc. Return On Assets for the quarter ending September 30, 2024 was -88.1 %, a 33.7% decline year-over-year.
  • Cue Biopharma, Inc. annual Return On Assets for 2023 was -71.1 %, a 15.1% decline from 2022.
  • Cue Biopharma, Inc. annual Return On Assets for 2022 was -61.8 %, a 19.2% decline from 2021.
  • Cue Biopharma, Inc. annual Return On Assets for 2021 was -51.9 %, a 6.56% decline from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -71.1 -9.33 -15.1% Jan 1, 2023 Dec 31, 2023
2022 -61.8 -9.96 -19.2% Jan 1, 2022 Dec 31, 2022
2021 -51.9 -3.19 -6.56% Jan 1, 2021 Dec 31, 2021
2020 -48.7 +23.4 +32.5% Jan 1, 2020 Dec 31, 2020
2019 -72 +5 +6.49% Jan 1, 2019 Dec 31, 2019
2018 -77 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.